Kala Pharmaceuticals snags $110 mln from Athyrium
Athyrium Capital Management LP has provided an $110 million credit facility to Waltham, Massachusetts-based Kala Pharmaceuticals, a biopharmaceutical firm. Morgan Stanley was the sole structuring agent on the transaction.
3 October 2018•4 mins read
